SKI Market

Indian Indices

Nifty

25,149.85 -205.40
(-0.81%)

Sensex

82,500.47 -689.81
( -0.83%)

Bank Nifty

56,754.70 -201.30
( -0.35%)

Nifty IT

37,693.25 -683.40
( -1.78%)

Global Indices

Nasdaq

44,384.39 -287.26
(-0.64%)

Dow Jones

6,279.98 -21.48
(-0.34%)

Hang Seng

39,553.98 -92.38
(-0.23%)

Nikkei 225

8,941.12 -34.54
(-0.38%)

Forex

USD-INR

85.68 -0.05
(-0.06%)

EUR-INR

100.36 -0.05
(-0.05%)

GBP-INR

116.41 -0.07
(-0.06%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Syncom Formulations (India) Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524470

INE312C01025

3.6159574

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SYNCOMF

36.27

1772.84

EPS(TTM)

Face Value()

Div & Yield %

0.52

Back

vasudhagama enterprises ltd

Mefcom Capital Markets reports consolidated net loss of Rs 0.99 crore in the December 2024 quarter

Feb 11,2025

Net loss of Mefcom Capital Markets reported to Rs 0.99 crore in the quarter ended December 2024 as against net profit of Rs 3.40 crore during the previous quarter ended December 2023. Sales declined 39.91% to Rs 40.72 crore in the quarter ended December 2024 as against Rs 67.76 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	40.72	67.76	-40
OPM %	-2.33	5.46	-
PBDT	-0.99	3.65	PL
PBT	-1.01	3.63	PL
NP	-0.99	3.40	PL

25,149.85 -205.40 (-0.81%)

82,500.47 -689.81 ( -0.83%)

56,754.70 -201.30 ( -0.35%)

37,693.25 -683.40 ( -1.78%)

44,384.39 -287.26 (-0.64%)

6,279.98 -21.48 (-0.34%)

39,553.98 -92.38 (-0.23%)

8,941.12 -34.54 (-0.38%)

85.68 -0.05 (-0.06%)

100.36 -0.05 (-0.05%)

116.41 -0.07 (-0.06%)

0.59 0.00 (0.19%)